Want to see JP:7061 full AI Analyst Report?

Japan Hospice Holdings Inc. (7061) Price & Analysis

0 Followers

7061 Stock Chart & Stats

¥1120.00

¥7.00(0.51%)

At close: Jan 08 4:00 PM EST

¥1120.00

¥7.00(0.51%)

Day’s Range― - ―

52-Week Range¥509.00 - ¥1,578.00

Previous CloseN/A

Volume53.20K

Average Volume (3M)47.89K

Market Cap

¥4.47B

Enterprise Value¥15.86B

Total Cash (Recent Filing)¥1.40B

Total Debt (Recent Filing)¥12.70B

Price to Earnings (P/E)14.7

Beta1.05

Next Earnings

Aug 07, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.41%

Share Statistics

EPS (TTM)64.07

Shares Outstanding8,484,100

10 Day Avg. Volume91,680

30 Day Avg. Volume47,890

Financial Highlights & Ratios

PEG Ratio-0.59

Price to Book (P/B)2.56

Price to Sales (P/S)0.66

P/FCF Ratio-7.11

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)199.5

Revenue Forecast (FY)¥20.00B

Bulls Say, Bears Say

Bulls Say

Revenue Growth TrendMulti-year top-line growth from 2020–2025, including ~8% revenue growth in 2025, indicates durable demand and successful expansion of services. Consistent revenue growth supports long-term capacity utilization and provides a stable base for margin recovery and steady cash generation over the medium term.

Essential Hospice Services ModelOperating in hospice and palliative care creates exposure to essential, less-cyclical healthcare needs. A facility-based, provider-partner model tends to produce recurring utilization and predictable demand, supporting steady occupancy and revenue resilience through economic cycles over the next several months.

Positive Operating Cash FlowOperating cash flow turning positive and improving to ~¥1.05B in 2025 shows core operations generate cash. While conversion versus net income is weak, sustained positive OCF provides a durable buffer to service day-to-day operations and near-term obligations without immediate reliance on equity issuance.

Bears Say

High LeverageDebt-to-equity around ~3.6x and rising absolute debt (~¥13.2B) materially limit financial flexibility. Elevated leverage increases refinancing and interest-rate vulnerability, constrains capital allocation, and raises the probability that external funding or restructuring may be needed if cash flow weakens further over the medium term.

Persistent Negative Free Cash FlowRepeated negative free cash flow, including deep deficits in 2024 and 2025, indicates investment and working-capital needs outpace operating cash generation. Persistent FCF shortfalls necessitate ongoing external financing, elevating liquidity and execution risk and limiting capacity for debt reduction or strategic investment.

Margin And Profitability DeteriorationMeaningful compression in gross and net margins and a decline in net income despite revenue growth signal rising costs or weakening pricing power. Lower profitability reduces internal funding for debt service and investment, making earnings recovery and balance-sheet repair more challenging over the medium term.

7061 FAQ

What was Japan Hospice Holdings Inc.’s price range in the past 12 months?

Japan Hospice Holdings Inc. lowest stock price was ¥509.00 and its highest was ¥1578.00 in the past 12 months.

What is Japan Hospice Holdings Inc.’s market cap?

Japan Hospice Holdings Inc.’s market cap is ¥4.47B.

When is Japan Hospice Holdings Inc.’s upcoming earnings report date?

Japan Hospice Holdings Inc.’s upcoming earnings report date is Aug 07, 2026 which is in 38 days.

How were Japan Hospice Holdings Inc.’s earnings last quarter?

Japan Hospice Holdings Inc. released its earnings results on May 15, 2026. The company reported ¥9.43 earnings per share for the quarter, beating the consensus estimate of N/A by ¥9.43.

Is Japan Hospice Holdings Inc. overvalued?

According to Wall Street analysts Japan Hospice Holdings Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Japan Hospice Holdings Inc. pay dividends?

Japan Hospice Holdings Inc. pays a Annually dividend of ¥25 which represents an annual dividend yield of 1.41%. See more information on Japan Hospice Holdings Inc. dividends here

What is Japan Hospice Holdings Inc.’s EPS estimate?

Japan Hospice Holdings Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Japan Hospice Holdings Inc. have?

Japan Hospice Holdings Inc. has 8,484,100 shares outstanding.

What happened to Japan Hospice Holdings Inc.’s price movement after its last earnings report?

Japan Hospice Holdings Inc. reported an EPS of ¥9.43 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.834%.

Which hedge fund is a major shareholder of Japan Hospice Holdings Inc.?

Currently, no hedge funds are holding shares in JP:7061

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Japan Hospice Holdings Inc.

Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable diseases. Beyond residential care, the company provides home-visit nursing and broader home care services. These home care offerings include medical assistance, physical care, and support for daily living, alongside multi-functional day and nursing care programs. The company was founded in 2017 and is headquartered in Tokyo, Japan.